These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10950467)

  • 1. Desipramine versus phenelzine in recurrent unipolar depression: clinical characteristics and treatment response.
    Swann AC; Bowden CL; Rush AJ; Rhoades H; Rose R; Kobes R
    J Clin Psychopharmacol; 1997 Apr; 17(2):78-83. PubMed ID: 10950467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of atypical depression with cognitive therapy or phenelzine: a double-blind, placebo-controlled trial.
    Jarrett RB; Schaffer M; McIntire D; Witt-Browder A; Kraft D; Risser RC
    Arch Gen Psychiatry; 1999 May; 56(5):431-7. PubMed ID: 10232298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment response of depressed outpatients unresponsive to both a tricyclic and a monoamine oxidase inhibitor antidepressant.
    McGrath PJ; Stewart JW; Nunes EN; Quitkin FM
    J Clin Psychiatry; 1994 Aug; 55(8):336-9. PubMed ID: 8071301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response of psychotic and nonpsychotic depression to phenelzine.
    Janicak PG; Pandey GN; Davis JM; Boshes R; Bresnahan D; Sharma R
    Am J Psychiatry; 1988 Jan; 145(1):93-5. PubMed ID: 3337297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential response patterns to MAO inhibitors and tricyclics.
    Nies A
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):70-7. PubMed ID: 6376487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Columbia atypical depression. A subgroup of depressives with better response to MAOI than to tricyclic antidepressants or placebo.
    Quitkin FM; Stewart JW; McGrath PJ; Tricamo E; Rabkin JG; Ocepek-Welikson K; Nunes E; Harrison W; Klein DF
    Br J Psychiatry Suppl; 1993 Sep; (21):30-4. PubMed ID: 8217065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lithium and desipramine versus desipramine alone in the treatment of severe major depression: a preliminary study.
    Cappiello A; McDougle CJ; Delgado PL; Malison RT; Jatlow P; Charney DS; Heninger GR; Price LH
    Int Clin Psychopharmacol; 1998 Sep; 13(5):191-8. PubMed ID: 9817623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MAOIs in the contemporary treatment of depression.
    Thase ME; Trivedi MH; Rush AJ
    Neuropsychopharmacology; 1995 May; 12(3):185-219. PubMed ID: 7612154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined MAOI, TCA, and direct stimulant therapy of treatment-resistant depression.
    Feighner JP; Herbstein J; Damlouji N
    J Clin Psychiatry; 1985 Jun; 46(6):206-9. PubMed ID: 3997787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and tolerability of tranylcypromine versus phenelzine: a double-blind study in antidepressant-refractory depressed inpatients.
    Birkenhäger TK; van den Broek WW; Mulder PG; Bruijn JA; Moleman P
    J Clin Psychiatry; 2004 Nov; 65(11):1505-10. PubMed ID: 15554763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The importance of dosage in prescribing antidepressants.
    Quitkin FM
    Br J Psychiatry; 1985 Dec; 147():593-7. PubMed ID: 3913485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluvoxamine in the treatment of tricyclic-resistant depression.
    White K; Wykoff W; Tynes LL; Schneider L; Zemansky M
    Psychiatr J Univ Ott; 1990 Sep; 15(3):156-8. PubMed ID: 2123039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treating DSM-IV depression with atypical features.
    Stewart JW; Thase ME
    J Clin Psychiatry; 2007 Apr; 68(4):e10. PubMed ID: 17474800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prior antidepressant treatment does not have an impact on response to desipramine treatment in major depression.
    Young LT; Cooke RG; Levitt AJ; Joffe RT
    Biol Psychiatry; 1995 Sep; 38(6):410-2. PubMed ID: 8547462
    [No Abstract]   [Full Text] [Related]  

  • 15. Fluoxetine versus phenelzine in atypical depression.
    Pande AC; Birkett M; Fechner-Bates S; Haskett RF; Greden JF
    Biol Psychiatry; 1996 Nov; 40(10):1017-20. PubMed ID: 8915561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tricyclic nonresponders: phenomenology and treatment.
    Roose SP; Glassman AH; Walsh BT; Woodring S
    Am J Psychiatry; 1986 Mar; 143(3):345-8. PubMed ID: 3953869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-tryptophan in depression.
    Farkas T; Dunner DL; Fieve RR
    Biol Psychiatry; 1976 Jun; 11(3):295-302. PubMed ID: 779855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenelzine for chronic depression: a study of continuation treatment.
    Harrison W; Rabkin J; Stewart JW; McGrath PJ; Tricamo E; Quitkin F
    J Clin Psychiatry; 1986 Jul; 47(7):346-9. PubMed ID: 3522558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brofaromine in depression: a Canadian multicenter placebo trial and a review of standard drug comparative studies.
    Chouinard G; Saxena BM; Nair NP; Kutcher SP; Bakish D; Bradwejn J; Kennedy SH; Sharma V; Remick RA; Kukha-Mohamad SA
    Clin Neuropharmacol; 1993; 16 Suppl 2():S51-4. PubMed ID: 8313397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical effects of abrupt withdrawal from tri-cyclic antidepressants and monoamine oxidase inhibitors after long-term treatment.
    Tyrer P
    J Affect Disord; 1984 Feb; 6(1):1-7. PubMed ID: 6231324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.